1.20

0.83% -0.00

Bionano Genomics Inc (BNGO)

Overview News Price History Option Chain Financials Why BNGO Down? Discussions Forecast Stock Split

Bionano Genomics Inc stock is traded at $1.20, with a volume of 95,945. It is down -0.83% in the last 24 hours and up +3.48% over the past month. Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Previous Close:

$1.20

Open:

$1.18

24h Volume:

95,945

Relative Volume:

0.30

Market Cap:

$12.11M

Revenue:

$28.51M

Net Income/Loss:

$-26.40M

P/E Ratio:

-0.2192

EPS:

-5.4756

Net Cash Flow:

$-16.35M

1W Performance:

+6.25%

1M Performance:

+3.48%

6M Performance:

-28.31%

1Y Performance:

-61.86%

1-Day Range:

$1.18

$1.21

1-Week Range:

$1.1093

$1.47

52-Week Range:

$1.06

$5.50

Bionano Genomics Inc Stock (BNGO) Company Profile

Name

Bionano Genomics Inc

Sector

Healthcare (1117)

Industry

Medical Instruments & Supplies (58)

Phone

(858) 888-7600

Address

9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA

Employee

100

Twitter

@bionanogenomics

Next Earnings Date

2026-03-23

Latest SEC Filings

BNGO's Discussions on Twitter

Compare BNGO vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BNGO Bionano Genomics Inc	1.19	12.21M	28.51M	-26.40M	-16.35M	-5.4756
ISRG Intuitive Surgical Inc	468.20	166.92B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	157.72	45.02B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	75.28	36.68B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	42.40	34.63B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	225.56	32.97B	5.40B	1.49B	1.78B	10.12

Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Downgrade	Ladenburg Thalmann	Buy → Neutral
Sep-10-24	Downgrade	BTIG Research	Buy → Neutral
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Dec-12-22	Resumed	BTIG Research	Buy
Jul-18-22	Resumed	Oppenheimer	Outperform
Jun-16-21	Initiated	BTIG Research	Buy
Sep-24-20	Initiated	Ladenburg Thalmann	Buy
Apr-08-20	Initiated	Oppenheimer	Outperform

View All

Bionano Genomics Inc Stock (BNGO) Latest News

Mar 25, 2026

Bionano outlines $30M–$33M revenue target for 2026 with focus on routine user growth and margin expansion - MSN

Mar 25, 2026

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 earnings call transcript - MSN

Mar 25, 2026

Mar 24, 2026

Bionano Genomics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-03-24 - Seeking Alpha

Mar 24, 2026

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 24, 2026

Bionano Genomics Reports 2025 Financial Results, Highlights OGM Adoption and Announces 2026 Revenue Outlook - Minichart

Mar 24, 2026

Bionano Genomics earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN

Mar 24, 2026

Bionano Genomics 2025 Annual Report Highlights: Optical Genome Mapping, Market Expansion, and Risk Factors 57596054 - Minichart

Mar 24, 2026

Bionano Q4 2025 slides: margins surge 47% as cost cuts offset revenue dip - Investing.com Canada

Mar 24, 2026